ArdelyxMEX:ARDX 69 FCF Yield % is -2.94 as of Jul. 02, 2026. GuruFocus rates MEX:ARDX with a GF Score™ of 69/100 and a GF Value™ of MXN195.32 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,414 Biotechnology companies, Ardelyx ranks better than 71.15% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Ardelyx's Trailing 12-Month Free Cash Flow is MXN-693 Mil, and Market Cap is MXN22,331 Mil. Therefore, Ardelyx's FCF Yield % for today is -2.94%.
The historical rank and industry rank for Ardelyx's FCF Yield % or its related term are showing as below:
MEX:ARDX'
s FCF Yield % Range Over the Past 10 Years
Min: -196.78 Med: -16.36 Max: -2.22
Current: -2.94
During the past 13 years, the highest FCF Yield % of Ardelyx was -2.22%. The lowest was -196.78%. And the median was -16.36%.
MEX:ARDX's FCF Yield % is ranked better than 71.15% of 1414
companies
in the Biotechnology industry
Industry Median: -9.485
vs MEX:ARDX: -2.94
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ardelyx FCF Yield % Related Terms
Ardelyx FCF Yield % Historical Data
* Premium members only.
The historical data trend for Ardelyx's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ARDX vs AVLN, INBX, JBIO: FCF Yield % Comparison
For the Biotechnology subindustry, Ardelyx's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ardelyx FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ardelyx's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Ardelyx's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ardelyx (MEX:ARDX) has a FCF Yield % of -2.94 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ardelyx and its competitors. According to the industry distribution chart, Ardelyx ranks #408 out of 1414 companies in the Biotechnology industry, placing it in the top 28.9%.
Is Ardelyx's FCF Yield % too high?
Ardelyx's current FCF Yield % is -2.94. Based on the distribution chart, Ardelyx ranks #408 out of 1414 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ardelyx has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ardelyx's FCF Yield % compare to AVLN and INBX?
According to the Biotechnology industry distribution chart, Ardelyx ranks #408 out of 1414 companies for FCF Yield %. This puts Ardelyx in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ardelyx and its competitors. Ardelyx's current FCF Yield % is -2.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ardelyx stock overvalued right now?
Based on GuruFocus' analysis, Ardelyx (MEX:ARDX) is currently considered Possible Value Trap. The stock's GF Value™ is MXN195.32, compared to a current price of MXN99.00 — trading 49.3% below its estimated fair value. The current FCF Yield % is -2.94. Ardelyx's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ardelyx (MEX:ARDX), the current FCF Yield % is -2.94 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ardelyx (MEX:ARDX) Overvalued in 2026?
Based on GuruFocus' analysis, Ardelyx stock appears to be undervalued.
The current stock price of MXN99.00 is trading 49.3% below its estimated GF Value™ of MXN195.32.
GuruFocus considers Ardelyx to be Possible Value Trap.
Key valuation signals for MEX:ARDX:
FCF Yield %: -2.94
GF Value™: MXN195.32 vs. price of MXN99.00 (49.3% below fair value)
No single metric tells the full story. See the MEX:ARDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
69GF Score
Get the complete analysis for MEX:ARDX
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ARDX has been successfully added to your 
